Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Oncology|August 28, 2010
A multicenter phase II trial with irinotecan plus oxaliplatin as first-line treatment for inoperable/metastatic cancer of the biliary tractNiki Karachaliou, Aris Polyzos, Nikolaos Kentepozidis, et al.
Lung Cancer (Amsterdam, Netherlands)|May 14, 2004
High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding studyCharalambos Kouroussis, Dimitris Mavroudis, Stylianos Kakolyris, et al.
Lung Cancer (Amsterdam, Netherlands)|October 13, 2006
Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): a multicenter phase II studyStylianos Kakolyris, Nikolaos Ziras, Lambros Vamvakas, et al.
Gastroenterology Research and Practice|June 14, 2012
Preliminary results of hyperthermic intraperitoneal intraoperative chemotherapy as an adjuvant in resectable pancreatic cancerAntonios-Apostolos K Tentes, Dimitrios Kyziridis, Stylianos Kakolyris, et al.
American Journal of Clinical Oncology|December 3, 2011
Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacyMaria G Riga, Leonidas Chelis, Stylianos Kakolyris, et al.
American Journal of Clinical Oncology|December 13, 2002
Oxaliplatin with high-dose leucovorin and infusional 5-fluorouracil in irinotecan-pretreated patients with advanced colorectal cancer (ACC)Charalambos Kouroussis, John Souglakos, Dimitris Mavroudis, et al.
International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancerJohn Souglakos, Nikolaos Androulakis, Dimitrios Mavroudis, et al.
Medical Hypothesis, Discovery & Innovation Ophthalmology Journal|March 5, 2015
Lung cancer and eye metastasesSofia Lampaki, Ioannis Kioumis, Georgia Pitsiou, et al.
Anticancer Research|April 12, 2003
A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancerCharalambos Kouroussis, Sophia Agelaki, Dimitris Mavroudis, et al.
Molecular Oncology|January 4, 2025
Detection rate for ESR1 mutations is higher in circulating-tumor-cell-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCRStavroula Smilkou, Aliki Ntzifa, Victoria Tserpeli, et al.
Pageof 7